India vs Sur: Cases started on MDR-TB treatment

India
51,765
in 2024
Sur
10
in 2024
India rank
1st
Sur rank
1st

Cases started on MDR-TB treatment over time

  • India
  • Sur
020.0k40.0k60.0k200820162024

How they compare

India currently reports 51,765 against 10 in Sur, a difference of 51,755.

That makes India's figure about 5,176.5 times Sur's.

Across all 16 years both countries report, India has been ahead every year.

India ranks 1st and Sur ranks 1st of 193 countries.

India has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade India Sur Difference Ahead
2000s 663 0.5 662.5 India
2010s 29,626 0 29,626 India
2020s 53,302 3.8 53,298 India

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cases started on mdr-tb treatment, India or Sur?
India, at 51,765 against 10 in Sur as of 2024.
What is the difference in cases started on mdr-tb treatment between India and Sur?
51,755, with India ahead.
How many years of comparable data are there for India and Sur?
16 years are reported by both, from 2008 to 2024.
How do India and Sur rank globally for cases started on mdr-tb treatment?
India ranks 1st and Sur ranks 1st of 193 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed